Can People Without Viral Suppression Benefit From Cabenuva? - POZ
8/19/2022 12:00:00 AM3 years 6 months ago
Most people in a pilot program at a safety-net HIV clinic achieved viral suppression on the long-acting injectable regimen.
Long-acting Cabenuva (cabotegravir and rilpivirine) injections may be an option for people with HIV who are unable to achieve viral suppression due to challenges with treatment adherence, according t… [+8536 chars]
full article...